Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease : the Multi-Ethnic Study of Atherosclerosis (MESA)

Circulation

Volumn 133, Issue 9, 2016, Pages 849-858

  Blaha, Michael J ^a,i   Cainzos Achirica, Miguel ^a,b   Greenland, Philip ^c   McEvoy, John W ^a   Blankstein, Ron ^d   Budoff, Matthew J ^e   Dardari, Zeina ^a   Sibley, Christopher T ^f   Burke, Gregory L ^g   Kronmal, Richard A ^h   Szklo, Moyses ⁱ   Blumenthal, Roger S ^a   Nasir, Khurram ^a,j  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

more..

Author keywords

Biomarkers; calcium; cardiac imaging techniques; cardiovascular diseases; risk assessment

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HOMOCYSTEINE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CORONARY ARTERY CALCIUM SCORE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; VERY ELDERLY; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; CORONARY BLOOD VESSEL; ETHNIC GROUP; ETHNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK FACTOR;

AGED; ATHEROSCLEROSIS; BIOMARKERS; C-REACTIVE PROTEIN; CALCIUM; CARDIOVASCULAR DISEASES; COHORT STUDIES; CORONARY VESSELS; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84959502403     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.018524     Document Type: Article

References (37)

1. 27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events: September 14-15, 1995. J Am Coll Cardiol. 1996;27:957-1047.
2. World Health Organization. Global Status Report on Non-Communicable Diseases 2010. Geneva, Switzerland: World Health Organization; 2011.
3. Kildemoes HW, Andersen M, Støvring H. The impact of ageing and changing utilization patterns on future cardiovascular drug expenditure: a pharmacoepidemiological projection approach. Pharmacoepidemiol Drug Saf. 2010;19:1276-1286. doi: 10.1002/pds.2039.
4. Karmali KN, Goff DC Jr, Ning H, Lloyd-Jones DM. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2014;64:959-968. doi: 10.1016/j.jacc.2014.06.1186.
5. Pencina MJ, Navar-Boggan AM, D'Agostino RB Sr, Williams K, Neely B, Sniderman AD, Peterson ED. Application of new cholesterol guidelines to a population-based sample. N Engl J Med. 2014;370:1422-1431. doi: 10.1056/NEJMoa1315665.
6. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PWF. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S1-S45.
7. Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013;382:1762-1765. doi: 10.1016/S0140-6736(13)62388-0.
8. Hecht HS. A zero coronary artery calcium score: priceless. J Am Coll Cardiol. 2010;55:1118-1120. doi: 10.1016/j.jacc.2009.09.064.
9. Sarwar A, Shaw LJ, Shapiro MD, Blankstein R, Hoffmann U, Hoffman U, Cury RC, Abbara S, Brady TJ, Budoff MJ, Blumenthal RS, Nasir K. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging. 2009;2:675-688. doi: 10.1016/j. jcmg.2008.12.031.
10. Janssens AC, Deng Y, Borsboom GJ, Eijkemans MJ, Habbema JD, Steyerberg EW. A new logistic regression approach for the evaluation of diagnostic test results. Med Decis Making. 2005;25:168-177. doi: 10.1177/0272989X05275154.
11. Gu W, Pepe MS. Estimating the capacity for improvement in risk prediction with a marker. Biostatistics. 2009;10:172-186. doi: 10.1093/biostatistics/kxn025.
12. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O'Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871-881.
13. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-438. doi: 10.1161/01. CIR.0000111245.75752.C6.
14. Bertoni AG, Whitt-Glover MC, Chung H, Le KY, Barr RG, Mahesh M, Jenny NS, Burke GL, Jacobs DR. The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2009;169:444-454. doi: 10.1093/aje/kwn350.
15. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(suppl 2):S49-S73. doi: 10.1161/01. cir.0000437741.48606.98.
16. Sharma K, Blaha MJ, Blumenthal RS, Musunuru K. Clinical and research applications of carotid intima-media thickness. Am J Cardiol. 2009;103:1316-1320. doi: 10.1016/j.amjcard.2009.01.020.
17. Bots ML, Westerink J, Rabelink TJ, de Koning EJ. Assessment of flowmediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J. 2005;26:363-368. doi: 10.1093/eurheartj/ehi017.
18. Tison GH, Ndumele CE, Gerstenblith G, Allison MA, Polak JF, Szklo M. Usefulness of baseline obesity to predict development of a high ankle brachial index (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2011;107:1386-1391. doi: 10.1016/j. amjcard.2010.12.050.
19. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195-2207. doi: 10.1056/NEJMoa0807646.
20. Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S, Afonso L. Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol. 2011;58:1025-1033. doi: 10.1016/j. jacc.2011.05.028.
21. Sanchez OA, Duprez DA, Daniels LB, Maisel AS, Otvos JD, Peralta CA, Lima JA, Bahrami H, Jacobs DR Jr. The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis. Metabolism. 2015;64:857-861. doi: 10.1016/j.metabol.2015.04.001.
22. Toto RD. Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens (Greenwich). 2004;6(suppl 3):2-7.
23. Ahmed HM, Blaha MJ, Nasir K, Jones SR, Rivera JJ, Agatston A, Blankstein R, Wong ND, Lakoski S, Budoff MJ, Burke GL, Sibley CT, Ouyang P, Blumenthal RS. Low-risk lifestyle, coronary calcium, cardiovascular events, and mortality: results from MESA. Am J Epidemiol. 2013;178:12-21. doi: 10.1093/aje/kws453.
24. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935. doi: 10.1161/CIRCULATIONAHA.106.672402.
25. Fontana M, Asaria P, Moraldo M, Finegold J, Hassanally K, Manisty CH, Francis DP. Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility. Circulation. 2014;129:2539-2546. doi: 10.1161/CIRCULATIONAHA.113.007595.
26. Blaha MJ, Silverman MG, Budoff MJ. Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease Clinical risk scores are not sufficient to define primary prevention treatment strategies among asymptomatic patients. Circ Cardiovasc Imaging. 2014;7:398-408; discussion 408. doi: 10.1161/CIRCIMAGING.113.000341.
27. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336-1345. doi: 10.1056/NEJMoa072100.
28. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115:459-467. doi: 10.1161/CIRCULATIONAHA.106.628875.
29. Peters SA, den Ruijter HM, Bots ML, Moons KG. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart. 2012;98:177-184. doi: 10.1136/heartjnl-2011-300747.
30. Tota-Maharaj R, Blaha MJ, McEvoy JW, Blumenthal RS, Muse ED, Budoff MJ, Shaw LJ, Berman DS, Rana JS, Rumberger J, Callister T, Rivera J, Agatston A, Nasir K. Coronary artery calcium for the prediction of mortality in young adults <45 years old and elderly adults > 75 years old. Eur Heart J. 2012;33:2955-2962. doi: 10.1093/eurheartj/ehs230.
31. Silverman MG, Blaha MJ, Krumholz HM, Budoff MJ, Blankstein R, Sibley CT, Agatston A, Blumenthal RS, Nasir K. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. Eur Heart J. 2014;35:2232-2241. doi: 10.1093/eurheartj/eht508.
32. Gardin JM, Bartz TM, Polak JF, O'Leary DH, Wong ND. What do carotid intima-media thickness and plaque add to the prediction of stroke and cardiovascular disease risk in older adults The Cardiovascular Health Study. J Am Soc Echocardiogr. 2014;27:998-1005.e2. doi: 10.1016/j. echo.2014.06.013.
33. Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link J Am Coll Cardiol. 2013;62:397-408. doi: 10.1016/j.jacc.2013.05.016.
34. Ciampi A, Courteau J, Niyonsenga T, Xhignesse M, Lussier-Cacan S, Roy M. Family history and the risk of coronary heart disease: comparing predictive models. Eur J Epidemiol. 2001;17:609-620.
35. Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, Krestin GP, Oudkerk M, de Maat MP, Leebeek FW, Mattace-Raso FU, Lindemans J, Hofman A, Steyerberg EW, van der Lugt A, van den Meiracker AH, Witteman JC. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156:438-444. doi: 10.7326/0003-4819-156-6-201203200-00006.
36. Simon A, Chironi G, Levenson J. Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. Eur Heart J. 2007;28:2967-2971. doi: 10.1093/eurheartj/ehm487.
37. Pepe MS, Feng Z, Gu JW. Comments on "Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond" by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008;27:173-181. doi: 10.1002/sim.2991.